AdaptHealth Corp. announced its first quarter 2025 financial results, reporting a net revenue of $777.9 million, a 1.8% decrease compared to the previous year. The company experienced a net loss of $7.2 million and a 19.3% decrease in Adjusted EBITDA to $127.9 million. Despite these declines, cash flow from operations significantly increased to $95.5 million.
Net revenue decreased by 1.8% to $777.9 million compared to $792.5 million in Q1 2024.
The company reported a net loss attributable to AdaptHealth Corp. of $7.2 million, a larger loss than the $2.1 million in Q1 2024.
Adjusted EBITDA declined by 19.3% to $127.9 million from $158.5 million in the prior year.
Cash flow from operations saw a substantial increase to $95.5 million from $49.0 million in Q1 2024.
AdaptHealth is updating its fiscal year 2025 financial guidance to reflect the disposition of certain incontinence assets, with revised net revenue and Adjusted EBITDA ranges, while free cash flow guidance remains unchanged.
Analyze how earnings announcements historically affect stock price performance